Early Phase Unit

The focus of emovis is on working with patients. Phase I-Ib studies are usually conducted with healthy participants to test new treatment methods. Increasingly, however, patients are also involved in this early phase. This is referred to as "adaptive designs". The aim is to shorten the path from the first-time human trial to proof of concept as much as possible. - And this is where emovis comes in. As a Clinical Service Provider with a great deal of experience, emovis can offer the valuable combination of 1) competence and dedication, as well as 2) the ability to recruit a large number of patients with quality, care and speed.

We offer phase I-Ib studies for many different indications and conduct them at our study site as well as in our sleep laboratory.

In line with our motto: We always rise to the challenge of making the impossible possible, we strive to find solutions for you and the participants in our clinical trials.

emovis offers a rare combination of

• the infrastructure and experience to conduct phase I-Ib clinical trials
• extensive experience with psychiatric indications and assessment scales
• experienced staff (all trained according to ICH/GCP and IATA)

What else we are known for:

• We have both phase I and Phase IIIV study conduct experience.
• We guarantee full patient safety!
• We offer extensive knowhow in various indication areas such as psychosomatic diseases.

Organizationally, the sleep lab is part of our study site. For more information about the study process, indications, success stories, or answers to frequently asked questions, please visit the Dedicated Study Site subpage.

Would you like to receive further information from us?

We are looking forward to receiving your request at: feasibility@emovis.de.